InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Jhaveri Nirav S.. Insider active across 3 companies, notably Ocuphire Pharma, Inc.. Aggregated, 5 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €19k. History available since 12 February 2024. The latest transaction was disclosed on 17 August 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Jhaveri Nirav S. is Chief Financial Officer at Opus Genetics, Inc., Ocuphire Pharma, Inc. and Longeveron Inc. He has 5 filings in total, and within the sampled recent filings the activity spans 2024-02-14 to 2026-08-25, with EUR 19201 of buys and EUR 0 of sells, and the stated transaction nature is Attribution.